Related Experiment Video
Updated: Nov 10, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Using Published Health Utilities in Cost-Utility Analyses: Discrepancies and Issues in Cardiovascular Disease
Ting Zhou1,2, Zhiyuan Chen2, Hongchao Li1
1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.
Insights
Discrepancies in health utilities used in cardiovascular disease cost-utility analyses (CUAs) are common. Authors must cite original studies and be transparent about utility selection to ensure CUA credibility.
Area of Science:
- Health economics
- Medical decision making
- Cardiovascular disease research
Background:
- Health utilities are crucial for quality-adjusted life years in cost-utility analysis (CUA).
- Improper use of published health utilities can undermine CUA credibility.
Purpose of the Study:
- To identify and analyze discrepancies in the application of published health utilities within cardiovascular disease (CVD) cost-utility analyses.
Main Methods:
- Reviewed 585 CVD CUAs from the Tufts Cost-Effectiveness Analysis Registry.
- Compared 2235 health utilities from 442 CUAs against 203 original utility studies.
- Utilized logistic regression to identify factors predicting discrepancies.
Main Results:
- Only 26.7% of health utilities matched original descriptions and values.
- 44.3% differed in both description and value, often due to disease severity.
- 87.4% of value discrepancies lacked justification.
Conclusions:
- Significant discrepancies exist in health utility usage for CVD CUAs.
- Authors must reference original utility studies and ensure transparency in selection and application.
- Accurate health utility reporting is essential for reliable cost-utility analyses.
Background:
Health utilities are commonly used as quality weights to calculate quality-adjusted life years in cost-utility analysis (CUA). However, if published health utilities are not properly used, the credibility of CUA could be affected.
Objectives:
To identify discrepancies in using published health utilities in CUAs for cardiovascular disease (CVD).
Methods:
CVD CUAs in the Tufts Cost-Effectiveness Analysis Registry that reported health utilities were included in the analysis. References cited for health utilities in these CUAs were reviewed to identify the original health utility studies. The description and value of health utilities used in the CUA were compared with those reported in the original utility studies. Logistic regression was used to identify the factors that can predict the discrepancy.
Results:
A total of 585 eligible CUAs published between 1977 and 2016 were identified and reviewed. Of these studies, 74.5% were published between 2007 and 2016. 442 CUAs that used a total of 2235 health utilities published in 203 original utility studies were included for the comparison. As compared with those utilities originally reported, only 596 (26.7%) health utilities had the same description and value, whereas 991 health utilities (44.3%) differed in both description and value. Of 1290 health utilities with a different description, 69.1% were due to different severity or disease. No explanation or justification was provided for 1171 (87.4%) of 1340 health utilities with different value.
Conclusions:
There are concerning discrepancies in using published health utilities for CVD CUAs. Given the important role health utilities play in CUAs, authors of CUAs should always refer to the original studies for health utilities and be transparent about how published health utilities are selected and incorporated into CUAs.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Bioequivalence Data: Statistical Interpretation
Bias in Epidemiological Studies
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Volume of Distribution
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test